Rady Children's Specialists of San Diego
Rady Children's Specialists
University of Toronto Ontario Canada
Hospital for Sick Children, University of Toronto
National Institutes of Health, NIH
Dr. Jane Kim is a board-certified pediatric endocrinologist at Rady Children's Hospital-San Diego and an assistant professor in the Division of Pediatric Endocrinology at UC San Diego School of Medicine.
Her medical education began at the University of Toronto, followed by a pediatric residency at the Hospital for Sick Children. Committed to pursuing endocrine research that integrates molecular biology and clinical medicine, Dr. Kim moved to the National Institutes of Health headquarters in Bethesda, Md., where she completed her pediatric endocrinology fellowship. To gain additional expertise in diabetes research, she went on to complete her postdoctoral research training at the Naomi Berrie Diabetes Center at Columbia University, New York. She then joined the faculty at UC San Diego in 2004.
Dr. Kim provides clinical care for children with all types of pediatric endocrine conditions. As a physician-scientist, she conducts both basic science and clinical research to better understand the causes and complications of insulin resistance and diabetes, with the goal of discovering new treatments.
Additionally, Dr. Kim instructs and mentors medical students, residents and fellows at the UC San Diego School of Medicine.
When not working, Dr. Kim enjoys spending time with her family. She also enjoys music and was trained in classical music as a pianist.
Dual actions of a novel bifunctional compound to lower glucose in mice with diet-induced insulin resistance.
Chen K, Jih A, Kavaler ST, Lagakos WS, Oh D, Watkins SM, Kim JJ
Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes.
Kim JJ, Tan Y, Xiao L, Sun YL, Qu X
The fractalkine/CX3CR1 system regulates Î² cell function and insulin secretion.
Lee YS, Morinaga H, Kim JJ, Lagakos W, Taylor S, Keshwani M, Perkins G, Dong H, Kayali AG, Sweet IR, Olefsky J
GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.
Xu J, Morinaga H, Oh D, Li P, Chen A, Talukdar S, Mamane Y, Mancini JA, Nawrocki AR, Lazarowski E, Olefsky JM, Kim JJ
G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice.
Osborn O, Oh DY, McNelis J, Sanchez-Alavez M, Talukdar S, Lu M, Li P, Thiede L, Morinaga H, Kim JJ, Heinrichsdorff J, Nalbandian S, Ofrecio JM, Scadeng M, Schenk S, Hadcock J, Bartfai T, Olefsky JM
Putting the brakes on FOXO1 in fat.
Kim JJ, Fan W, Olefsky JM
Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency.
Kavaler S, Morinaga H, Jih A, Fan W, Hedlund M, Varki A, Kim JJ
FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.
Fan W, Morinaga H, Kim JJ, Bae E, Spann NJ, Heinz S, Glass CK, Olefsky JM
TLR4 and Insulin Resistance.
Kim JJ, Sears DD
The effects and mechanism of saponins of Panax notoginseng on glucose metabolism in 3T3-L1 cells.
Kim JJ, Xiao H, Tan Y, Wang ZZ, Paul Seale J, Qu X
FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue.
Kim JJ, Li P, Huntley J, Chang JP, Arden KC, Olefsky JM
FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes.
Fan W, Imamura T, Sonoda N, Sears DD, Patsouris D, Kim JJ, Olefsky JM
Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2.
Kim JJ, Kido Y, Scherer PE, White MF, Accili D
APPLied mechanics: uncovering how adiponectin modulates insulin action.
Hosch SE, Olefsky JM, Kim JJ
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.